Iron overload syndromes and the liver

Modern Pathology

Volumn 20, Issue 1, 2007, Pages 31-39

  Batts, Kenneth P ^a  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

Hemochromatosis; Iron; Liver; Review

Indexed keywords

FERRITIN; FERROPORTIN 1; HEMOJUVELIN; HEPCIDIN; IRON; TRANSFERRIN RECEPTOR 2;

ALCOHOL LIVER DISEASE; BLOOD TRANSFUSION; CELLULAR DISTRIBUTION; GENE MUTATION; GENETIC ANALYSIS; HEMOCHROMATOSIS; HEMOLYTIC ANEMIA; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LABORATORY TEST; LIVER CIRRHOSIS; LIVER DISEASE; MACROPHAGE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVIEW;

HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; IRON OVERLOAD; LIVER; MEMBRANE PROTEINS; MUTATION; SYNDROME;

EID: 34248337416     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800715     Document Type: Article

References (43)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class-1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;14:399-408.
2. Edwards CQ, Ajioka RS, Kushner JP. Hemochromatosis: a genetic definition. In: Barton JC, Edwards CQ (eds). Hemochromatosis. Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge University Press: Cambridge, 2000, pp 8-11.
3. Yen AW, Fancher TI, Bowlus CL. Revisiting hereditary hemochromatosis: current concepts and progress. Am J Med 2006;119:391-399.
4. Wessling-Resnic M. Iron Imports III. Transfer of iron from the mucosa into circulation. Am J Physiol Gastrointest Liver Physiol 2006;290:G1-G6.
5. Ganz T, Nemeth E. Iron Imports IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointestinal Liver Physiol 2006;290:G199-G203.
6. Pietrangelo A, Trautwein C. Mechanisms of disease: the role of hepcidin in iron homeostasis—implications for hemochromatosis and other disorders. Nat Clin Prac Gastroenterol Hepatol 2004;1:39-45.
7. von Recklinghausen FD. Uber hemochromatose. Tagelb Versamml Natur Artze Heidelberg 1889;62:324-325.
8. Sheldon JH. Haemochromatosis. Oxford University Press: London, 1935.
9. Davis WD, Arrowsmith WR. The effect of repeated phlebotomies in hemochromatosis; report of three cases. J Lab Clin Med 1952;39:526-532.
10. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 1962;84:53-64.
11. Simon M, Pawlotsky Y, Bourel M, et al. Hemochromatose idiopathique: maladie associee a l’antigene tissulaire HLA 3. Nouv Presse Med 1975;19:1432.
12. Fleming RE, Britton RS, Waheed A, et al. Pathogenesis of hereditary hemochromatosis. Clin Liver Dis 2004;8: 755-773.
13. Roetto A, Camaschella C. New insights into iron homeostasis thought the study of non-HFE hereditary haemochromatosis. Best Practice Res Clin Haematol 2005;18:235-250.
14. Fairbanks VF. Population genetics. In: Barton JC, Edwards CQ (eds). Hemochromatosis. Genetics, Pathophysiology, Diagnosis, and Treatment. Cambridge University Press: Cambridge, 2000, pp 42-50.
15. Pointon JJ, Wallace D, Merryweather-Clarke AT, et al. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genetic Test 2000;4:151-161.
16. Gochee PA, Powell LW, Clullen DJ, et al. A populationbased study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-651.
17. Aquilar-Martinez P, Schved JF, Brissot P. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities. Am J Gastroenterol 2005;100:1185-1194.
18. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 2000;105:1209-1216.
19. Brissot P, Troadec MB, Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr Haematol Rep 2004;3:107-115.
20. Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Practice Res 2005; 18:203-220.
21. Beutler E, Felitti VJ, Koziol JA, et al. Penetrance of 845G-A (282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218.
22. DeDomenico I, Ward DM, Musci G, et al. Iron overload due to mutations in ferroportin. Haemoatologica 2006; 91:92-95.
23. Celec P. Hemojuvelin: a supposed role in iron metabolism one year after its discovery. J Mol Med 2005;83:521-525.
24. Whitington PF. Fetal and infantile hemochromatosis. Hepatology 2006;43:654-660.
25. Brunt EM, Olynyk JK, Britton RS, et al. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol 2000;95:1788-1893.
26. Deugnier YM, Loreal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their biochemical correlations. Gastroenterology 1992;102:2050-2059.
27. Powell E, Ali A, Clouston AD, et al. Steatosis is a cofactor in liver injury in hemochromatosis. Am J Gastroenterol 2005;129:1937-1943.
28. Laine F, Jouannolle A-M, Morcet J, et al. Phenotypic expression in detected C282Y homozygous women depends on body mass index. J Hepatol 2005;43: 1055-1059.
29. Deugnier YM, Guyader D, Crantock L, et al. Primary liver cancer in genetic hemochromatosis: a clinical, pathogenetic study of 54 cases. Gastroenterology 1993; 104:228-234.
30. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
31. Ludwig JL, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-888.
32. Fiel MI, Schiano TD, Bodenheimer HC, et al. Hereditary hemochromatosis in liver transplantation. Liver Transplant Surg 1999;5:50-56.
33. Duane P, Raja KB, Simpson RJ, et al. Intestinal iron absorption in chronic alcoholics. Alcohol Alcoholism 1992;27:539-544.
34. Powell LW, Fletcher LM, Halliday JW. Distinction between haemochromatosis and alcoholic siderosis. In: Hall P (ed). Alcoholic Liver Disease, 2nd edn. Edward Arnold: London, 1995, pp 199-216.
35. Fabris C, Toniutto P, Scott CA, et al. Serum iron indices as a measure of iron deposits in chronic hepatitis D. Clin Chim Acta 2001;304: 49-55.
36. Yano M, Hayashi H, Waksawa S, et al. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C. Am J Gastroenterol 2002;97:133-137.
37. Hofer H, Osterreicher C, Jessner W, et al. Hepatic iron concentration does not predict response to standard and pgylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol 2004;40: 1018-1022.
38. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-29.
39. LeSage GD, Baldus WP, Fairbanks VF, et al. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983;84:1471-1477.
40. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited; prevalence and clinical consequences among homozygous siblings. Hepatology 1996;23:724-727.
41. Irving MG, Halliday JW, Powell LW. Association between alcoholism and increased hepatic iron stores. Alcohol: Clin Exp Res 1988;12:7-13.
42. Deugnier YM, Turlin B, Powell LW, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993;19:30-34.
43. Olynyk J, Hall P, Sallie R, et al. Computerized measurement of iron in liver biopsies: a comparision with biochemical iron measurement. Hepatology 1990; 12:26-30.